Clinical Trial Update: A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of AZD3427 in participants with heart failure and World Health Organization Group 2 pulmonary hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Pulmonary Hypertension

Drugs mentioned

• AZD3427

Snippet

Sponsor: AstraZeneca | Conditions: Pulmonary Hypertension (World Health Organization Group 2), Heart Failure | Phase 2 | Status: COMPLETED